Jeremy Adler, MD, MSc
Clinical Professor, Department of Pediatrics, Division of Pediatric Gastroenterology
Address:
1500 E. Medical Center Drive
MPB D5200, Box SPC5718
Ann Arbor, MI 48109-5718
Biography
Jeremy Adler, M.D., M.Sc. is a Clinical Professor in the Division of Pediatric Gastroenterology at the University of Michigan. Dr. Adler earned his M.D. degree at the University of South Florida College of Medicine. He completed his residency in pediatrics at Boston City Hospital and Boston Medical Center in 1997. He then practiced academic general pediatrics in New York for several years before moving to Michigan to train in pediatric gastroenterology at the University of Michigan. He then earned a Master of Science in Health and Health Care Research through in the Horace H. Rackham School of Graduate Studies at the University of Michigan, and had further training in the Advanced Improvement Methods program at Cincinnati Children’s Hospital. Dr. Adler joined the pediatric gastroenterology faculty at the University of Michigan in 2008.
Dr. Adler’s clinical and research interest is in the care of children and adolescents with Crohn’s disease and ulcerative colitis (inflammatory bowel disease or IBD). His research focus is on improving short and long-term outcomes and health related quality of life for children with IBD. He has been working on developing evidence-based strategies for preventing disease related complications such as fistulas and pouchitis, and to mitigate disparities among children with IBD.
Dr. Adler is an NIH-funded researcher whose scientific research has been featured in the American Gastroenterology Association’s headline news, on the cover of the journal Inflammatory Bowel Diseases, and in the Innovations in Health Care section of the Wall Street Journal. Dr. Adler is a leader in the field of pediatric IBD, and has served as consultant to the US Food and Drug Administration, and his work on prevention of disease complications and on developing methods for evaluating endoscopic findings has been used in national and international policies and guidelines on treating children and adults with IBD. Dr. Adler also serves as the Director of Research and Quality Improvement in Pediatric Gastroenterology, and as the Director of the Pediatric IBD Program at C.S. Mott Children’s Hospital at Michigan Medicine.
Education
MSc, Health and Healthcare Research, University of Michigan, 2009
MD, University of South Florida, 1994
BS, University of Florida, 1990
Projects
Selected Publications
Weaver KN, Zhang X, Dai X, Chen W, Watkins R, Adler J, Dubinsky MC, Kastl A, Bousvaros A, Strople JA, Cross RK, Higgins PDR, Ungaro RC, Bewtra M, Bellaguarda E, Farraye FA, Craig R, Hernandez C, Boccieri ME, Firestine A, Chun KY, Long MD, Kappelman MD. Low Rates of Breakthrough COVID-19 Infection After SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2023 Mar 1;29(3):483-486. doi: 10.1093/ibd/izac138. PMID: 35830416; PMCID: PMC9384490.
Singh S, Ananthakrishnan AN, Nguyen NH, Cohen BL, Velayos FS, Weiss JM, Sultan S, Siddique SM, Adler J, Chachu KA; AGA Clinical Guidelines Committee. AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis. Gastroenterology. 2023 Mar;164(3):344-372. doi: 10.1053/j.gastro.2022.12.007. PMID: 36822736.
Lawrence LS, Heider A, Singer AAM, Neef HC, Adler J. Granulomas in Diagnostic Biopsies Associated With High Risk of Crohn’s Complications-But May Be Preventable. Inflamm Bowel Dis. 2022 Mar 30;28(4):523-530. doi: 10.1093/ibd/izab109. PMID: 33999198.
Singer AAM, Rompca A, Gadepalli SK, Adler J. Predictors of Perianal Fistula Healing in Children With Newly Diagnosed Crohn Disease. J Pediatr Gastroenterol Nutr. 2022 Dec 1;75(6):709-716. doi: 10.1097/MPG.0000000000003595. Epub 2022 Aug 24. PMID: 36399175.
Weaver KN, Zhang X, Dai X, Watkins R, Adler J, Dubinsky MC, Kastl A, Bousvaros A, Strople JA, Cross RK, Higgins PDR, Ungaro RC, Bewtra M, Bellaguarda E, Farraye FA, Boccieri ME, Firestine A, Kappelman MD, Long MD. Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID. Inflamm Bowel Dis. 2022 Oct 3;28(10):1497-1505. doi: 10.1093/ibd/izab302. PMID: 34871388; PMCID: PMC8822409.
Samalik JM, Goldberg CS, Modi ZJ, Fredericks EM, Gadepalli SK, Eder SJ, Adler J. Discrepancies in Race and Ethnicity in the Electronic Health Record Compared to Self-report. J Racial Ethn Health Disparities. 2022 Nov 23. doi: 10.1007/s40615-022-01445-w. Epub ahead of print. PMID: 36418736.
Adler J, Eder SJ, Gebremariam A, Moran CJ, Bass LM, Moses J, Lewis JD, Singer AAM, Morhardt TL, Picoraro JA, Cardenas V, Zacur GM, Colletti RB. Quantification of Mucosal Activity from Colonoscopy Reports via the Simplified Endoscopic Mucosal Assessment for Crohn’s Disease. Inflamm Bowel Dis. 2022 Oct 3;28(10):1537-1542. doi: 10.1093/ibd/izab315. PMID: 34964861.
Adler J, Colletti RB, Noonan L, Berzin TM, Cheifetz AS, Conklin LS, Hoops TC, Huang CS, Lewis B, Mishkin DS, Hung Lo K, Xiao Y, Volger S. Validating the Simplified Endoscopic Mucosal Assessment for Crohn’s Disease: A Novel Method for Assessing Disease Activity. Inflamm Bowel Dis. 2022 Sep 1:izac183. doi: 10.1093/ibd/izac183. Epub ahead of print. PMID: 36049024.
Adler J, Lee GJ, Singer AAM. Do Not Stop Anti-TNF Medications in Children With IBD When They Are Working. Inflamm Bowel Dis. 2022 Feb 1;28(2):322-324. doi: 10.1093/ibd/izab047. PMID: 33835170.
Kandavel P, Eder SJ, Adler J; and the ImproveCareNow Network Pediatric IBD Learning Health System. Reduced Systemic Corticosteroid Use among Pediatric Patients With Inflammatory Bowel Disease in a Large Learning Health System. J Pediatr Gastroenterol Nutr. 2021 Sep 1;73(3):345-351. doi: 10.1097/MPG.0000000000003182. PMID: 34415262.
Rubalcava NS, Moreno NA, Adler J, Geiger JD, Hirschl RB, Gadepalli SK. Does the timing of pouch creation in 2-stage operations for pediatric patients with ulcerative colitis matter? J Pediatr Surg. 2021 Jun;56(6):1203-1207. doi: 10.1016/j.jpedsurg.2021.02.023. Epub 2021 Feb 20. PMID: 33741179.
Adler J, Lin CC, Gadepalli SK, Dombkowski KJ. Association Between Steroid-Sparing Therapy and the Risk of Perianal Fistulizing Complications Among Young Patients With Crohn Disease. JAMA Netw Open. 2020 Jun 1;3(6):e207378. doi: 10.1001/jamanetworkopen.2020.7378. PMID: 32515798; PMCID: PMC7284306.